Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity

BMC Medical Genetics

Si Houn Hahn²  Nguyen-Thao B Tran¹  John Penn¹  Valeria Vasta¹  Jeana T DaRe³ 

[1] Seattle Children’s Hospital Research Institute, 1900 9th Ave, Seattle, WA 98101, USA;Department of Pediatrics, Division of Genetic Medicine, University of Washington, School of Medicine/Seattle Children’s Hospital, 4800 Sand Point Way, Seattle, WA 98105, USA;Transgenomic, Inc, 5 Science Park, New Haven, CT 06511, USA

关键词: Targeted exome;    Next-generation sequencing;    Electron transport chains;    Respiratory chain complexes;    Mitochondrial disorder;   

Others  :  1122581
DOI  :  10.1186/1471-2350-14-118

 received in 2013-07-22, accepted in 2013-11-06,  发布年份 2013

【 摘 要 】

Background

Mitochondrial disorders are difficult to diagnose due to extreme genetic and phenotypic heterogeneities.

Methods

We explored the utility of targeted next-generation sequencing for the diagnosis of mitochondrial disorders in 148 patients submitted for clinical testing. A panel of 447 nuclear genes encoding mitochondrial respiratory chain complexes, and other genes inducing secondary mitochondrial dysfunction or that cause diseases which mimic mitochondrial disorders were tested.

Results

We identified variants considered to be possibly disease-causing based on family segregation data and/or variants already known to cause disease in twelve genes in thirteen patients. Rare or novel variants of unknown significance were identified in 45 additional genes for various metabolic, genetic or neurogenetic disorders.

Conclusions

Primary mitochondrial defects were confirmed only in four patients indicating that majority of patients with suspected mitochondrial disorders are presumably not the result of direct impairment of energy production. Our results support that clinical and routine laboratory ascertainment for mitochondrial disorders are challenging due to significant overlapping non-specific clinical symptoms and lack of specific biomarkers. While next-generation sequencing shows promise for diagnosing suspected mitochondrial disorders, the challenges remain as the underlying genetic heterogeneity may be greater than suspected and it is further confounded by the similarity of symptoms with other conditions as we report here.

【 授权许可】

   
2013 DaRe et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Wong LJ, Cohen BH, Naviaux RK: The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008, 94(1):16-37.
• [2]Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, Laskowski A, Garone C, Liu S, Jaffe DB, et al.: Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 2012, 4(118):118ra110.
• [3]Gellerich FN, Mayr JA, Reuter S, Sperl W, Zierz S: The problem of interlab variation in methods for mitochondrial disease diagnosis: enzymatic measurement of respiratory chain complexes. Mitochondrion 2004, 4(5-6):427-439.
• [4]Oglesbee D, Freedenberg D, Kramer KA, Anderson BD, Hahn SH: Normal muscle respiratory chain enzymes can complicate mitochondrial disease diagnosis. Pediatr Neurol 2006, 35(4):289-292.
• [5]Chen X, Thorburn DR, Wong LJ, Vladutiu GD, Haas RH, Le T, Hoppel C, Sedensky M, Morgan P, Hahn SH: Quality improvement of mitochondrial respiratory chain complex enzyme assays using Caenorhabditis elegans. Genet Med 2011, 13(9):794-799.
• [6]Tsurusaki Y, Osaka H, Hamanoue H, Shimbo H, Tsuji M, Doi H, Saitsu H, Matsumoto N, Miyake N: Rapid detection of a mutation causing X-linked leucoencephalopathy by exome sequencing. J Med Genet 2011, 48(9):606-609.
• [7]Meder B, Haas J, Keller A, Heid C, Just S, Borries A, Boisguerin V, Scharfenberger-Schmeer M, Stahler P, Beier M, et al.: Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet 2011, 4(2):110-122.
• [8]Amstutz U, Andrey-Zurcher G, Suciu D, Jaggi R, Haberle J, Largiader CR: Sequence capture and next-generation resequencing of multiple tagged nucleic acid samples for mutation screening of urea cycle disorders. Clin Chem 2011, 57(1):102-111.
• [9]Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, et al.: Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011, 3(65):65ra64.
• [10]Vasta V, Ng S, Turner E, Shendure J, Hahn S: Next generation sequence analysis for mitochondrial disorders. Genome Med 2009, 1(10):100. BioMed Central Full Text
• [11]Calvo SE, Tucker EJ, Compton AG, Kirby DM, Crawford G, Burtt NP, Rivas M, Guiducci C, Bruno DL, Goldberger OA, et al.: High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat Genet 2010, 42(10):851-858.
• [12]Briones P, Vilaseca MA, Garcia-Silva MT, Pineda M, Colomer J, Ferrer I, Artigas J, Jaeken J, Chabas A: Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. Eur J Paediatr Neurol 2001, 5(3):127-131.
• [13]Calvo SE, Mootha VK: The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet 2010, 11:25-44.
• [14]Scharfe C, Lu H, Neuenburg J, Allen E, Li G, Klopstock T, Cowan T, Enns G, Davis R: Mapping gene associations in human mitochondria using clinical disease phenotypes. PLoS Comput Biol 2009, 5(4):e1000374.
• [15]Vasta V, Merritt JL II, Saneto RP, Hahn SH: Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum. Pediatr Int 2012, 54(5):585-601.
• [16]Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR: Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002, 59(9):1406-1411.
• [17]Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25(14):1754-1760.
• [18]Albers CA, Lunter G, MacArthur DG, McVean G, Ouwehand WH, Durbin R: Dindel: accurate indel calls from short-read data. Genome Res 2011, 21(6):961-973.
• [19]Stenson P, Mort M, Ball E, Howells K, Phillips A, Thomas N, Cooper D: The human gene mutation database: 2008 update. Genome Med 2009, 1(1):13. BioMed Central Full Text
• [20]Clarke L, Zheng-Bradley X, Smith R, Kulesha E, Xiao C, Toneva I, Vaughan B, Preuss D, Leinonen R, Shumway M, et al.: The 1000 genomes project: data management and community access. Nat Methods 2012, 9(5):459-462.
• [21]Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249.
• [22]Tucker EJ, Hershman SG, Kohrer C, Belcher-Timme CA, Patel J, Goldberger OA, Christodoulou J, Silberstein JM, McKenzie M, Ryan MT, et al.: Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. Cell Metab 2011, 14(3):428-434.
• [23]Haack TB, Haberberger B, Frisch EM, Wieland T, Iuso A, Gorza M, Strecker V, Graf E, Mayr JA, Herberg U, et al.: Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing. J Med Genet 2012, 49(4):277-283.
• [24]Loeffen J, Elpeleg O, Smeitink J, Smeets R, Stockler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L: Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 2001, 49(2):195-201.
• [25]Sugiana C, Pagliarini D, McKenzie M, Kirby D, Salemi R, Abu-Amero K, Dahl H, Hutchison W, Vascotto K, Smith S, et al.: Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet 2008, 83(4):468-478.
• [26]Colombo I, Finocchiaro G, Garavaglia B, Garbuglio N, Yamaguchi S, Frerman FE, Berra B, DiDonato S: Mutations and polymorphisms of the gene encoding the beta-subunit of the electron transfer flavoprotein in three patients with glutaric acidemia type II. Hum Mol Genet 1994, 3(3):429-435.
• [27]Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ: A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001, 28(4):345-349.
• [28]Hommes FA, Bendien K, Elema JD, Bremer HJ, Lombeck I: Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand 1976, 65(2):233-240.
• [29]Barbosa M, Lopes A, Mota C, Martins E, Oliveira J, Alves S, De Bonis P, Mota Mdo C, Dias C, Rodrigues-Santos P, et al.: Clinical, biochemical and molecular characterization of cystinuria in a cohort of 12 patients. Clin Genet 2012, 81(1):47-55.
• [30]Copeland WC: Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol 2012, 47(1):64-74.
• [31]Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M: Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat 2006, 27(7):626-632.
• [32]Brugman F, Wokke JH, Scheffer H, Versteeg MH, Sistermans EA, van den Berg LH: Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann Neurol 2005, 58(6):865-869.
• [33]Skalova S, Neuman D, Lnenicka P, Stekrova J: Gitelman syndrome as a cause of psychomotor retardation in a toddler. Arab J Nephrol Transplant 2013, 6(1):37-39.
• [34]Gao H, Boustany RM, Espinola JA, Cotman SL, Srinidhi L, Antonellis KA, Gillis T, Qin X, Liu S, Donahue LR, et al.: Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet 2002, 70(2):324-335.
• [35]Flanagan SE, Patch AM, Ellard S: Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers 2010, 14(4):533-537.
• [36]Hicks S, Wheeler DA, Plon SE, Kimmel M: Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum Mutat 2011, 32(6):661-668.
• [37]Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, Shi Y: Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations. Endocrine 2011, 40(1):14-20.
• [38]Ghezzi D, Baruffini E, Haack TB, Invernizzi F, Melchionda L, Dallabona C, Strom TM, Parini R, Burlina AB, Meitinger T, et al.: Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am J Hum Genet 2012, 90(6):1079-1087.
• [39]Steenweg ME, Ghezzi D, Haack T, Abbink TE, Martinelli D, Van Berkel CG, Bley A, Diogo L, Grillo E, Te Water NJ, et al.: Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’ caused by EARS2 mutations. Brain 2012, 135(Pt 5):1387-1394.
• [40]Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, Hershman SG, Gold NB, Chapman BA, Thorburn DR, Berry GT, et al.: Targeted exome sequencing of suspected mitochondrial disorders. Neurology 2013, 80(19):1762-1770.
• [41]Dinwiddie DL, Smith LD, Miller NA, Atherton AM, Farrow EG, Strenk ME, Soden SE, Saunders CJ, Kingsmore SF: Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome. Genomics 2013, 102(3):148-156.
• [42]Gahl WA, Markello TC, Toro C, Fajardo KF, Sincan M, Gill F, Carlson-Donohoe H, Gropman A, Pierson TM, Golas G, et al.: The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med 2012, 14(1):51-59.
• [43]Ronchi D, Garone C, Bordoni A, Gutierrez Rios P, Calvo SE, Ripolone M, Ranieri M, Rizzuti M, Villa L, Magri F, et al.: Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain 2012, 135(Pt 11):3404-3415.
• [44]Wang J, Cui H, Lee NC, Hwu WL, Chien YH, Craigen WJ, Wong LJ, Zhang VW: Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med 2013, 15(2):106-114.
• [45]Vielhaber S, Debska-Vielhaber G, Peeva V, Schoeler S, Kudin AP, Minin I, Schreiber S, Dengler R, Kollewe K, Zuschratter W, et al.: Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol 2013, 125(2):245-256.
• [46]Hui J, Kirby DM, Thorburn DR, Boneh A: Decreased activities of mitochondrial respiratory chain complexes in non-mitochondrial respiratory chain diseases. Dev Med Child Neurol 2006, 48(2):132-136.
• [47]Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF: Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008, 83(2):254-260.
• [48]Lieber DS, Vafai SB, Horton LC, Slate NG, Liu S, Borowsky ML, Calvo SE, Schmahmann JD, Mootha VK: Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease. BMC Med Genet 2012, 13:3.
• [49]Gentil BJ, Cooper L: Molecular basis of axonal dysfunction and traffic impairments in CMT. Brain Res Bull 2012, 88(5):444-453.
• [50]Zeviani M, Simonati A, Bindoff LA: Ataxia in mitochondrial disorders. Handb Clin Neurol 2012, 103:359-372.